Offices in Oklahoma, Texas
and Arkansas

Gadolinium Injury Lawsuits

Gadolinium Lawsuits in Tulsa, OKGadolinium is injected into a vein to increase the ability to see internal parts of the body when a patient gets an MRI (magnetic resonance image). This is an FDA approved material.

Some patients have developed NSF (nephrogenic systemic fibrosis) or NFD (nephrogenic fibrosing dermopathy) after being exposed. NSF and NFD are a type of kidney failure associated with Gadolinium.

The role of this contrast agent in an MRI is that it helps the doctor to tell the difference between tissue and blood vessels within the body.

The Tulsa Gadolinium injury lawyers at The Edwards Law Firm are accepting inquiries from those that have suffered these side effects after being exposed to Gadolinium.

For more information and a free review of your claim, contact us today by calling 1-800-304-9246. There are no upfront costs.

Common Side Effects of Gadolinium Exposure

These kidney conditions may develop suddenly or over a longer period of time.

The first sign of these diseases is tightening and swelling of the skin in the arms and legs. This causes the skin to become thick and prevent the patient from being able to flex and extend at the joints due to extreme pain.

This can progress to the point where the individual becomes almost immobile. Skin changes such as dark areas of skin, red skin, and other skin maladies have also been reported.

The affected person may also have soreness in the hip and rib area, and burning and itching of the skin.

Gadolinium Side Effects Lawsuits

Gadolinium Injury AttorneysIf you or someone you know has been a victim of this defective medical product, call our pharmaceutical injury lawyers today at 1-800-304-9246 for your free case assessment.

At the Edwards Law Firm, our goal is to hold the pharmaceutical companies responsible on your behalf. If we determine that you have a case, we will do everything possible to get justice.

You pay nothing if we do not succeed in obtaining compensation for you from the drug company, through mediation or as a result of a jury trial.

Back to Top